The scientific collaboration

ClinicalTrials.gov Identifier: NCT06509776


Early life determinants of skeletal maturation and endocrine health in young adults
 A nationwide birth cohort


EPIPEAK




Why study early life factors and young adult health?

In recent years it has become increasingly clear that intrauterine and early life exposures have consequences for adult health. Research has been challenging due to the scarcity of data on early life, other than birth weight records, for diseases that become manifest some decades into adult life. For the skeleton, it is unknown if the amount of bone laid down during the teenage years is pre-programmed as a chrono-switch or if peak bone mass (PBM) merely reflects mechano-sensing so that bone gain ends not due to a certain age being reached but due to the skeleton reaching a ‘sufficient’ mechanical competence to meet the demands. It is unclear, for example, if low bone mass due to anorexia or ill health in the teenage years can be recovered in the 3rd decade of life or if a chronostat mechanism prevents further gain. As a disease of late adulthood, osteoporosis research has focused little on bone health in young adulthood.


While epigenetic modifications could be transient, differences in DNA methylation in genes known to be associated with bone mass have been demonstrated between bone tissue from healthy postmenopausal women and women with osteoporosis suggesting persistence through adult life. Moreover, though the consequences of severe hormonal excess or deficits in infancy are well known to endocrinologists, not least for the thyroid axis, we have had few or no opportunities to study the effects of more subtle and/or transient differences on subsequent adult health. However, achieved dried blood spots (DBS) collected at birth may provide an opportunity to study such associations, and our group demonstrated the feasibility of using DBS measured vitamin D status at birth in relation to various childhood and adulthood health outcomes, including childhood fractures and epigenetic analyses in DBS are also feasible.


In summary, factors driving persistent hormonal changes, body size and bone mass in young adults are very poorly understood. Thus, to advance this research further, studies that make use of material collected at birth, and life course measures of bone density and growth, are needed. The present research proposal fills this gap, by including an in-depth examination of the influence of already prospectively collected early life indicators that may serve as determinants, and we propose to combine register data and archived biological material through establishing a new population-based cohort of 2,000 18-year-olds for assessment of hormonal status, lipids, bone turnover markers, bone mineral density, fat mass and lean body mass as outcomes.


What we aim to do:

The project addresses whether the following sets of potential determinants are associated with young adult hormonal status, lipids, bone turnover markers, bone mineral density (BMD), fat mass and lean body mass at age 18 years: a) maternal risk factors during preconception and pregnancy; b) risk factors at birth; c) neonatal epigenetic signature; d) childhood risk factors.


Study design and methods:

Population-based, nationwide, cross-sectional, clinical study (n=2,000) with already available early life exposure data including bio banked neonatal biological samples (Dried Blood Spots, DBS).
The Danish Civil registration system will be used to identify all 18-year-old individuals born in Denmark, i.e., live births from year 2006 and 2007.


The eligibility criteria are the following:

Inclusion criteria

  • Individuals (n=2,000) born in Denmark in 2006 or 2007
  • Are 18 years old and alive at the time of the clinical examination

Exclusion criteria

  • Pregnancy or lactation
  • No DBS samples available
  • Lack of consent to use DBS samples or national health registries
  • Emigration or disappearance


International collaborators

  • MRC Lifecourse Epidemiology Centre, University of Southampton
    Professor Nick Harvey, Director
    Beth Curtis, associate professor


The study diagram displays an overview of the project aims and work packages:


Epipeak study diagram


Early Life and Young Adult Health

Dried Blood Spots and Epigenetics at birth


Neonatal DBS samples by heel prick within 72 hours after birth have been collected for all newborns in Denmark, since the initiation of routine screening for congenital disorders in 1981. Epigenetic mechanisms include DNA methylation, histone modifications and non-coding RNAs(ncRNAs). Crucially, reliability of DNA extraction in DBS and feasibility of DNA methylation measurement in array technologies has been demonstrated previously. We will employ updated EPIC array and/or Blood Methylation Array for maximum efficiency and we will prioritize epigenetic changes in genes involved directly in endocrine signalling (hormones, receptors, co-receptors and downstream – e.g. CASR, AP2S1, CYP27B1, ESR1, HGR, GHRH, GHSR, GNAS, HSD11B1, HSD11B2, IGF1, IGF1R, PTH, TG, THRA, THRB, TRH, TRHR, VDR and others) or and those previously linked to low bone mineral density and with methylation changes in osteoporosis (eg MEPE, RANKL, WNT16, SOST, WIF1, DKK1).



Curtis EM, Fuggle NR, Cooper C, Harvey NC. Epigenetic regulation of bone mass. Best Pract Res Clin Endocrinol Metab 2022 Mar;36(2):101612.
Krstic N, Bishop N, Curtis B, Cooper C, Harvey N, Lilycrop K, et al. Early life vitamin D depletion and mechanical loading determine methylation changes in the RUNX2, RXRA, and osterix promoters in mice. Genes Nutr 2022 May 26;17(1):7.
Reppe S, Lien TG, Hsu YH, Gautvik VT, Olstad OK, Yu R, et al. Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women. Epigenetics 2017 Aug;12(8):674-87.
Gicquel C, El-Osta A, Le BY. Epigenetic regulation and fetal programming. Best Pract Res Clin Endocrinol Metab 2008 Feb;22(1):1-16.
Tang WY, Ho SM. Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord 2007 Jun;8(2):173-82.


Endocrine status


Non-fasting blood samples are taken and a hair sample collected for cortisol measurement. Biochemistry includes TSH fT4 fT3  Estradiol Testosterone SHBG DHEA-S FSH LH Inhibin , IGF-1 IGF-BP3 PTH 25OHD3  PINP AP HbA1c Ca(ion) and bone formation marker PINP.




Bone Mineral Density and Body Composition


BMD of the spine and hip, and whole-body will be
examined using DXA. DXA will provide information about total and regional BMD. Whole-body DXA will also provide total body lean mass (kg) and fat mass (kg) measurements.


In centres with HRpQCT equipment available, HRpQCT of the distal radius and tibia will also be performed. This will provide additional structural information including cortical thickness, trabecular number, trabecular thickness, and vBMD. Current lifestyle related information will be collected, such as
physical activity, dietary habits, smoking, alcohol consumption, cannabis usage, and smoking.

Contact information

For questions or inquires, please contact:

Mina N. Händel (centralt contact person): mina.nicole.holmgaard.handel@regionh.dk